In a 7 to 4 vote, an advisory panel to the US Food and Drug Administration (FDA) determined that the potential benefits of ...

STOCKHOLM — Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has shown significant benefits in preventing major kidney disease, cardiovascular events, as well as mortality in patients ...

Prostate cancer screening tests lack specificity in detecting higher-grade tumors, but a new urine test could help detect ...

Drink a couple glasses of wine and feel only half as intoxicated as you normally would — and sustain less damage to your ...

An iron profile workup and dermatological findings, such as hyperpigmentation, resistant pruritus, alopecia, and vitiligo, ...

Agents in development would preserve lean body mass and further promote fat loss in people taking new antiobesity medications ...

New data add to the body of evidence favoring the aromatase inhibitor therapy plus ovarian suppression over tamoxifen for ...

Although the prevalence of migraine has remained largely unchanged for the past 30 years, migraine-associated disability ...

Although provincial screening programs include the most essential elements, many could improve aspects of quality, efficacy, ...

Estimating the risk for unprovoked seizures in the year following an ischemic stroke using a novel prognostic model may help ...

Lung cancer screening with low-dose CT (LDCT) can effectively evaluate a high-risk population for undiagnosed chronic ...

How much could AI transform an industry as stodgy as healthcare, where other technologies have failed time and time again?